The rapidly emerging ESBL-producing Escherichia coli O25-ST131 clone carries LPS core synthesis genes of the K-12 type

FEMS Microbiology Letters

Volumn 332, Issue 2, 2012, Pages 131-136

  Szijártó, Valéria ^a,b   Pal, Tibor ^c   Nagy, Gabor ^a   Nagy, Eszter ^a   Ghazawi, Akela ^c   Al Haj, Mohammed ^c   Kurdi, Sylvia El ^d   Sonnevend, Agnes ^c  

^a Arsanis Biosciences GmbH   (Austria)

^b UNIVERSITY OF PÉCS   (Hungary)

^c UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^d TAWAM HOSPITAL   (United Arab Emirates)

Author keywords

Escherichia coli; Extraintestinal; K 12; LPS core; O25; ST131

Indexed keywords

LIPOPOLYSACCHARIDE;

BACTERIAL GENE; BACTERIAL GENETICS; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CONTROLLED STUDY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FECES ANALYSIS; GENE LOCUS; HETEROZYGOTE; LETTER; MOLECULAR CLONING; NEW SPECIES; NONHUMAN; NUCLEOTIDE SEQUENCE; OPERON; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPECIES DIFFERENCE; URINARY TRACT INFECTION;

BETA-LACTAMASES; BIOSYNTHETIC PATHWAYS; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; EUROPE; GENES, BACTERIAL; HUMANS; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; SYNTENY; UNITED ARAB EMIRATES; URINARY TRACT INFECTIONS;

ESCHERICHIA COLI;

EID: 84862616953     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2012.02585.x     Document Type: Letter

References (21)

1. Al-Kaabi MR, Tariq WU & Hassanein AA (2011) Rising bacterial resistance to common antibiotics in Al Ain, United Arab Emirates. East Mediterr Health J 17: 479-484.
2. Amor K, Heinrichs DE, Frirdich E, Ziebell K, Johnson RP & Whitfield C (2000) Distribution of core oligosaccharide types in lipopolysaccharides from Escherichia coli. Infect Immun 68: 1116-1124.
3. Appelmelk BJ, An YQ, Hekker TA, Thijs LG, MacLaren DM & de Graaf J (1994) Frequencies of lipopolysaccharide core types in Escherichia coli strains from bacteraemic patients. Microbiology 140(Pt 5): 1119-1124.
4. Avasthi TS, Kumar N, Baddam R, Hussain A, Nandanwar N, Jadhav S & Ahmed N (2011) Genome of multidrug-resistant uropathogenic Escherichia coli strain NA114 from India. J Bacteriol 193: 4272-4273.
5. Blanco M, Alonso MP, Nicolas-Chanoine MH et al. (2009) Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 63: 1135-1141.
6. Clermont O, Bonacorsi S & Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66: 4555-4558.
7. CLSI (2010) Performance Standards for Antimicorbial Susceptibility Testing, M100-S20, Vol. 30. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA.
8. Currie CG, McCallum K & Poxton IR (2001) Mucosal and systemic antibody responses to the lipopolysaccharide of Escherichia coli O157 in health and disease. J Med Microbiol 50: 345-354.
9. Duda KA, Lindner B, Brade H, Leimbach A, Brzuszkiewicz E, Dobrindt U & Holst O (2011) The lipopolysaccharide of the mastitis isolate Escherichia coli strain 1303 comprises a novel O-antigen and the rare K-12 core type. Microbiology 157: 1750-1760.
10. Gautom RK (1997) Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day. J Clin Microbiol 35: 2977-2980.
11. Gibb AP, Barclay GR, Poxton IR & di Padova F (1992) Frequencies of lipopolysaccharide core types among clinical isolates of Escherichia coli defined with monoclonal antibodies. J Infect Dis 166: 1051-1057.
12. Gibbs RJ, Stewart J & Poxton IR (2004) The distribution of, and antibody response to, the core lipopolysaccharide region of Escherichia coli isolated from the faeces of healthy humans and cattle. J Med Microbiol 53: 959-964.
13. Heinrichs DE, Yethon JA & Whitfield C (1998) Molecular basis of structural diversity in the core region of the lipopolysaccharide of Escherichia coli and Salmonella enterica. Mol Microbiol 30: 221-232.
14. Morris D, Boyle F, Ludden C et al. (2011) Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone. Antimicrob Agents Chemother 55: 4935-4936.
15. Muller-Loennies S, Brade L & Brade H (2007) Neutralizing and cross-reactive antibodies against enterobacterial lipopolysaccharide. Int J Med Microbiol 297: 321-340.
16. Peirano G, Schreckenberger PC & Pitout JD (2011) Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131. Antimicrob Agents Chemother 55: 2986-2988.
17. Toh H, Oshima K, Toyoda A et al. (2010) Complete genome sequence of the wild-type commensal Escherichia coli strain SE15, belonging to phylogenetic group B2. J Bacteriol 192: 1165-1166.
18. Totsika M, Beatson SA, Sarkar S et al. (2011) Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms. PLoS ONE 6: e26578.
19. Van der Bij AK, Peirano G, Pitondo-Silva A & Pitout JD (2012) The presence of genes encoding for different virulence factors in clonally related Escherichia coli that produce CTX-Ms. Diagn Microbiol Infect Dis 72: 297-302.
20. Wirth T, Falush D, Lan R et al. (2006) Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 60: 1136-1151.
21. Woodford N, Turton JF & Livermore DM (2011) Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 35: 736-755.